Medtronic
Medtronic Medtronic Medtronic Medtronic

Posted By Dr. Francine Kaufman | January 24, 2012

I have been excited to be a part of the STAR 3 clinical trial since becoming the Chief Medical Officer of Medtronic. The 12 month study phase results of Star 3, published in the New England Journal of Medicine, showed that there was a significant reduction in A1C in those study participants using an integrated insulin pump and CGM (SAP) compared to those using multiple daily injections (MDI).  Read More >


Posted By Amanda Sheldon | July 26, 2011

At this year’s American Diabetes Association Scientific Sessions, new clinical data was released from the landmark STAR 3 Study which compared A1C reduction for people using an insulin pump integrated with CGM to those using multiple daily injections (MDI). We are excited to share this new data with you and hope it motivates you to keep up your good work managing diabetes.  Read More >


Innovating for life.

x

You are leaving Loop-Blog.com

You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.

Medtronic does not review or control the content on the other website, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.

If you want to visit the other website, click XXXXXX.com

If you do not want to visit the other website, click Cancel